PURPOSE OF REVIEW: Fungi have been suggested to play an important role in the pathogenesis of chronic rhinosinusitis (CRS). This review describes the recent knowledge concerning the role of fungi in the pathogenesis of CRS and allergic fungal rhinosinusitis (AFRS) and the clinical implications for treatment. RECENT FINDINGS: Recent studies show that, although there are several potential deficits in the innate and potentially also in the acquired immunity of CRS patients that might reduce or change their ability to react to fungi, there are not many arguments to suggest a causative role for fungi in CRS with or without nasal polyps. However, due to the intrinsic or induced change in immunity of CRS patients, fungi might have a disease-modifying role. The fact that AFRS is more prevalent in warm and humid areas may point to fungi as a factor in this disease. SUMMARY: Almost a decade after the launching of the hypothesis by Ponikau, the absence of convincing immunological data or evidence for clinical improvement of CRS upon therapy with antifungal agents now means that the hypothesis that fungi play a role in a majority of the cases of CRS has to be rejected and antifungal treatment should not be used.
PURPOSE OF REVIEW: Fungi have been suggested to play an important role in the pathogenesis of chronic rhinosinusitis (CRS). This review describes the recent knowledge concerning the role of fungi in the pathogenesis of CRS and allergic fungal rhinosinusitis (AFRS) and the clinical implications for treatment. RECENT FINDINGS: Recent studies show that, although there are several potential deficits in the innate and potentially also in the acquired immunity of CRSpatients that might reduce or change their ability to react to fungi, there are not many arguments to suggest a causative role for fungi in CRS with or without nasal polyps. However, due to the intrinsic or induced change in immunity of CRSpatients, fungi might have a disease-modifying role. The fact that AFRS is more prevalent in warm and humid areas may point to fungi as a factor in this disease. SUMMARY: Almost a decade after the launching of the hypothesis by Ponikau, the absence of convincing immunological data or evidence for clinical improvement of CRS upon therapy with antifungal agents now means that the hypothesis that fungi play a role in a majority of the cases of CRS has to be rejected and antifungal treatment should not be used.
Authors: Sudarshan Seshadri; Xiang Lu; Matthew R Purkey; Tetsuya Homma; Andrew Wonho Choi; Roderick Carter; Lydia Suh; James Norton; Kathleen E Harris; David B Conley; Atsushi Kato; Pedro C Avila; Barbara Czarnocka; Peter A Kopp; Anju T Peters; Leslie C Grammer; Rakesh K Chandra; Bruce K Tan; Zheng Liu; Robert C Kern; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2015-07-02 Impact factor: 10.793
Authors: Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas Journal: Clin Microbiol Rev Date: 2017-01 Impact factor: 26.132
Authors: Irene Zhang; Steven D Pletcher; Andrew N Goldberg; Bridget M Barker; Emily K Cope Journal: Front Microbiol Date: 2017-12-12 Impact factor: 5.640
Authors: Gerhard A Wiesmüller; Birger Heinzow; Ute Aurbach; Karl-Christian Bergmann; Albrecht Bufe; Walter Buzina; Oliver A Cornely; Steffen Engelhart; Guido Fischer; Thomas Gabrio; Werner Heinz; Caroline E W Herr; Jörg Kleine-Tebbe; Ludger Klimek; Martin Köberle; Herbert Lichtnecker; Thomas Lob-Corzilius; Rolf Merget; Norbert Mülleneisen; Dennis Nowak; Uta Rabe; Monika Raulf; Hans Peter Seidl; Jens-Oliver Steiß; Regine Szewszyk; Peter Thomas; Kerttu Valtanen; Julia Hurraß Journal: Allergo J Int Date: 2017-02-28
Authors: Brett J Green; Donald H Beezhold; Zane Gallinger; Carly S Barron; Rochelle Melvin; Toni A Bledsoe; Michael L Kashon; Gordon L Sussman Journal: Allergy Asthma Clin Immunol Date: 2014-03-25 Impact factor: 3.406